Optimizing Outcomes Before And After Car T-Cell Therapy In Patients With Large B-Cell Lymphoma

Optimizing outcomes before and after CAR T-cell therapy in patients with large B-cell lymphoma

Improving survival outcomes and optimizing CAR-T therapy in patients with DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Optimizing the Use of CAR T-Cell Therapy in Lymphoma

Advances in cellular therapies for lymphoma: the value of CAR-T therapy & optimizing patient outcome

VJHemOnc – Video Journal of Hematology & HemOnc

Strategies to optimize the outcomes of earlier-line patients treated with CAR T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Optimizing lymphodepletion chemotherapy in CAR-T therapy recipients

VJHemOnc – Video Journal of Hematology & HemOnc

How successful is CAR-T for B-cell lymphoma?

Outcomes in Progressive Large B-Cell Lymphomas Following CD19-Specific CAR T Cells

Targeted Oncology

Outcomes of autoSCT, alloSCT & CAR-T cell therapy in patients with TP53-altered MCL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T Cell Update: Therapy Improves Outcomes for Patients with B-cell Lymphoma

Risk factors to predict post-CD19 CAR-T cell therapy outcomes in patients with LBCL

VJHemOnc – Video Journal of Hematology & HemOnc

After CAR T Cell Therapy Follicular Lymphoma Patient Has Time On His Side

Dana-Farber Cancer Institute

Optimizing CAR T-Cell Therapy in Relapsed/Refractory ALL

American Society of Hematology

Dan's Story: CAR T-Cell Therapy Treatment for Lymphoma

Outcomes of CAR-T therapy in patients with refractory B-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Update on CAR T Cell Therapy for Diffuse Large B-Cell Lymphoma | LRF Webinars

Lymphoma Research Foundation

CAR T-Cell Therapy: How Does It Work?

Optimizing CAR-T therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Advancements and challenges in CAR-T cell therapy

Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy